166
Views
23
CrossRef citations to date
0
Altmetric
Review

Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect

, &
Pages 1161-1174 | Published online: 26 Jun 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Nathan Herrmann, Hui Jue Wang, Bing Xin Song, Kritleen K. Bawa & Krista L. Lanctôt. (2022) Risks and benefits of current and novel drugs to treat agitation in Alzheimer’s disease. Expert Opinion on Drug Safety 21:10, pages 1289-1301.
Read now
Rita Khoury, Charlotte Marx, Sidney Mirgati, Divya Velury, Binu Chakkamparambil & George T. Grossberg. (2021) AVP-786 as a promising treatment option for Alzheimer’s Disease including agitation. Expert Opinion on Pharmacotherapy 22:7, pages 783-795.
Read now
Ricardo P. Garay & George T. Grossberg. (2017) AVP-786 for the treatment of agitation in dementia of the Alzheimer’s type. Expert Opinion on Investigational Drugs 26:1, pages 121-132.
Read now
Marian W. Roman. (2015) NueDexta: A Treatment for Pseudobulbar Affect. Issues in Mental Health Nursing 36:12, pages 1019-1021.
Read now

Articles from other publishers (19)

Praful Kumar Majhi, Samir Sayyad, Pratyush Mishra, Sainath Kamte, Rajanikant Sahu, Goutam Ghosh & Bharat Bhusan Subudhi. (2023) Low‐volume plasma sampling for determination of dextromethorphan and dextrorphan in rat plasma: LC–MS/MS method and its application in pharmacokinetic study. Biomedical Chromatography 37:4.
Crossref
Sabine Allida, Allan House & Maree L Hackett. (2022) Pharmaceutical interventions for emotionalism after stroke. Cochrane Database of Systematic Reviews 2022:11.
Crossref
Saeed Shakiba, Nahid Fakhraei, Muhammad Imran Khan, Fatemeh Rastmanesh, Fatemeh Mohammadi, Mina Khalilzadeh, Khashayar Afshari, Nazgol-Sadat Haddadi, Arvin Haj-Mirzaian, Umut Kaan Ünal, Abbas Norouzi-Javidan & Ahmad-Reza Dehpour. (2021) Effect of dextromethorphan in the mouse forced swim and tail suspension tests: Evidence for involvement of the alpha receptors. Learning and Motivation 74, pages 101722.
Crossref
Amelia J. Hicks, Fiona J. Clay, Jennie L. Ponsford, Luke A. Perry, Mahesh Jayaram, Rachel Batty & Malcolm Hopwood. (2020) Pharmacotherapy for the Pseudobulbar Affect in Individuals Who Have Sustained a Traumatic Brain Injury: a Systematic Review. Neuropsychology Review 30:1, pages 28-50.
Crossref
Yannick Villeneuve, Diana Cruz-Santiago, Helene Masson & Doris Clerc. (2020) Treatment of pseudobulbar affect in a mixed neurodegenerative disorder with compounded quinidine capsules and dextromethorphan cough syrup. SAGE Open Medical Case Reports 8, pages 2050313X2092107.
Crossref
Eoin Finegan, Rangariroyashe H. Chipika, Stacey Li Hi Shing, Orla Hardiman & Peter Bede. (2019) Pathological Crying and Laughing in Motor Neuron Disease: Pathobiology, Screening, Intervention. Frontiers in Neurology 10.
Crossref
Mathew Hakimi & Carine W. Maurer. (2019) Pseudobulbar Affect in Parkinsonian Disorders: A Review. Journal of Movement Disorders 12:1, pages 14-21.
Crossref
Linda Nguyen & Rae R. Matsumoto. 2019. Psychopharmacology of Neurologic Disease. Psychopharmacology of Neurologic Disease 243 251 .
Fiona J. Clay, Amelia J. Hicks, Luke A. Perry, Jennie L. Ponsford, Mahesh Jayaram & Malcolm Hopwood. (2018) Pharmacotherapy for the pseudobulbar affect in individuals who have sustained a traumatic brain injury: a systematic review protocol. JBI Database of Systematic Reviews and Implementation Reports 16:9, pages 1739-1757.
Crossref
Abhijit Dey & Anuradha Mukherjee. 2018. Discovery and Development of Neuroprotective Agents from Natural Products. Discovery and Development of Neuroprotective Agents from Natural Products 237 320 .
Tao Liu, Jianjun Li, Shixiong Huang, Changqinq Li, Zhongyan Zhao, Guoqiang Wen & Feng Chen. (2017) Altered resting-state functional activity in isolated pontine infarction patients with pathological laughing and crying. Oncotarget 8:48, pages 84529-84539.
Crossref
Linda Nguyen, Anna L. Scandinaro & Rae R. Matsumoto. (2017) Deuterated (d6)-dextromethorphan elicits antidepressant-like effects in mice. Pharmacology Biochemistry and Behavior 161, pages 30-37.
Crossref
M. Cataldi. 2017. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Young D. Chang, Mellar P. Davis, Joshua Smith & Terrence Gutgsell. (2016) Pseudobulbar Affect or Depression in Dementia?. Journal of Pain and Symptom Management 51:5, pages 954-958.
Crossref
Linda Nguyen, Kelan L. Thomas, Brandon P. Lucke-Wold, John Z. Cavendish, Molly S. Crowe & Rae R. Matsumoto. (2016) Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders. Pharmacology & Therapeutics 159, pages 1-22.
Crossref
Geying Wang, Fei Teng, Yuhui Chen, Yuanhua Liu, Yancheng Li, Li Cai, Xu Zhang, Zhiyu Nie & Lingjing Jin. (2016) Clinical Features and Related Factors of Poststroke Pathological Laughing and Crying: A Case–Control Study. Journal of Stroke and Cerebrovascular Diseases 25:3, pages 556-564.
Crossref
Eman Bahrani, Chloe E. Nunneley, Sylvia Hsu & Joseph S. Kass. (2016) Cutaneous Adverse Effects of Neurologic Medications. CNS Drugs 30:3, pages 245-267.
Crossref
Victor W. Mark. (2016) Stroke and Behavior. Neurologic Clinics 34:1, pages 205-234.
Crossref
Andrew E. Budson & Paul R. Solomon. 2016. Memory Loss, Alzheimer's Disease, and Dementia. Memory Loss, Alzheimer's Disease, and Dementia 226 234 .